A Study to Assess the Effect of Rifampin on the Metabolism of Navitoclax

Clinical trial NCT01121133 · COMPLETED

Trial details

NCT number: NCT01121133
Sponsor: AbbVie
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Lymphoma, Including Chronic Lymphocytic Leukemia Solid Tumors

Start date: 2010-05-01
Primary completion: 2011-05-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.